Document text
Principal Investigator: Sarah Andrews
Organization: NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
Fiscal Year: 2024
Award: $6,981,494
Funding agency: National Institute of Allergy and Infectious Diseases
The Vaccine Immunology Program is responsible for the end point analyses of clinical vaccine, therapeutic and prevention trials carried out by the Vaccine Research Center and collaborates with intramural and extramural investigators. In addition, the VIP investigates basic B cell immunobiology to elucidate the mechanisms that inform the discovery and development of vaccines for public health, including HIV, Influenza, Ebola, Zika, Malaria, TB, SARS-CoV-2 plus other emerging and re-emerging infectious diseases. This includes development of sophisticated analyses that supports in-depth investigation of clinical vaccine trials, including highly qualified clinical assays for use in IND submissions and for product licensure purposes.
Terms: <2019 novel corona virus><2019 novel coronavirus><2019-nCoV><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Assay><B blood cells><B cell><B cells><B-Cells><B-Lymphocytes><B-cell><Bioassay><Biological Assay><COVID-19 virus><COVID19 virus><Clinical><CoV-2><CoV2><Collaborations><Communicable Diseases><Development><EXTMR><Ebola><Emerging Communicable Diseases><Emerging Infectious Diseases><Extramural><Extramural Activities><Goals><Grippe><HIV><Human Immunodeficiency Viruses><Immunobiology><Immunology><Immunophysiology><Infectious Disease Pathway><Infectious Diseases><Infectious Disorder><Influenza><Investigators><LAV-HTLV-III><Licensure><Lymphadenopathy-Associated Virus><Malaria><Paludism><Plasmodium Infections><Prevention trial><Public Health><Qualifying><Research Personnel><Researchers><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV2><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome related corona virus 2><Therapeutic Trials><Vaccine Clinical Trial><Vaccine Research><Vaccines><Virus-HIV><Wuhan coronavirus><ZIKA><clinical investigation><clinical trial analysis><coronavirus disease 2019 virus><coronavirus disease-19 virus><develop a vaccine><develop vaccines><development of a vaccine><developmental><hCoV19><nCoV2><programs><vaccination study><vaccination trial><vaccine development><vaccine study><vaccine trial><vaccine-related research>